Stay updated on Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe total number of study locations decreased from 172 to 171, and The First Affliated Hospital Of Fujian Medical University in Fuzhou, China, 350005 was removed from the locations list. The data shows updates on 2025-12-31.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe Locations section was expanded to include numerous new sites across the US, Canada, and several European and other international regions. Several existing site entries were removed, altering where participants may enroll.SummaryDifference2%

- Check48 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. This is an administrative version update and does not alter the study details or core page behavior.SummaryDifference0.0%

- Check54 days agoChange DetectedPublications section wording updated to indicate entries are automatically filled from PubMed and may not be about the study. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedNew recruitment site added in Tainan, Taiwan (00704) and an updated actual primary completion date (May 8, 2025).SummaryDifference0.3%

- Check90 days agoChange DetectedUpdated trial page with expanded amendment-driven protocol details, unblinding status, dosing, endpoints, and discontinuation rules; older, less detailed wording was removed in favor of the new content.SummaryDifference8%

Stay in the know with updates to Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combos in Untreated Hepatocellular Carcinoma Clinical Trial page.